/Affinia Therapeutics and Forge Biologics Announce AAV cGMP Manufacturing Partnership to Advance Affinia Therapeutics' Pipeline of Next-Generation Gene Therapies to the Clinic
NEWS
Affinia Therapeutics and Forge Biologics Announce AAV cGMP Manufacturing Partnership to Advance Affinia Therapeutics' Pipeline of Next-Generation Gene Therapies to the Clinic
PRNewswire
2024/11/13Affinia Therapeutics and Forge Biologics Announce AAV cGMP Manufacturing Partnership to Advance Affinia Therapeutics' Pipeline of Next-Generation Gene Therapies to the Clinic
Affinia Therapeutics logo (PRNewsfoto/Affinia Therapeutics)
Summary
/PRNewswire/ -- Affinia Therapeutics ("Affinia"), an innovative gene therapy company with a pipeline of rationally designed adeno-associated virus (AAV) gene...